Coya Therapeutics, Inc. (COYA)

4.76USD +4.62% (+0.21)

Over 1M: -1.0%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

4.4 4.6 4.8 5
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '23 — Operating Income: -3.6M Q4 '23 — Operating Income: 1.8M Q1 '24 — Operating Income: -5.5M Q2 '24 — Operating Income: -3.2M Q3 '24 — Operating Income: -4.5M Q4 '24 — Operating Income: -4.1M Q1 '25 — Operating Income: -7.7M Q2 '25 — Operating Income: -6.4M Q3 '25 — Operating Income: -2.4M Q4 '25 — Operating Income: -6M Q1 '26 — Operating Income: -7.6M Q2 '26 — Operating Income: -7M -6M -4M -2M 0 2M
Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Operating Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 66.3%
OE margin -262.3%
Oper. margin -288.7%
ROIC -19250.1%
Accruals -12.6%
EBITDA margin -288.5%
FCF margin -196.1%
OCF margin -196.1%
Profit margin -270.2%
ROA -45.8%
ROCE -52.9%
ROE -50.1%
Capex / sales —
Gross margin —
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

3.5
EV/Sales 8.5×
EV/OE -3.3×
P/C 2.6×
P/B 2.6×
FCF yield -14.1%
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

3.0
RPO / sales 0.15×
RPO growth —
Segment HHI —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

7.8
Current ratio 20.6×
ND/EBITDA 0.63
Cash runway 2.7 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 13.4×
F-score 2.6 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

6.6
Sales/sh Y/Y +1624.8%
Sales Q/Q +49.0%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —

2 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.